StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.45−0.05 (-3.33%)

Close on Nov 18, 2026Market cap $21.92MP/E –Yield –

CervoMed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CervoMed's operating cash flow for the twelve months ending Jun 30, 2026 was -$27.98M. For fiscal 2025 it was -$23.45M. The highest annual figure on record is -$1.18M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.45M–
FY2024Dec 31, 2024-$16.53M–
FY2023Dec 31, 2023-$7.45M–
FY2022Dec 31, 2022-$2.57M–
FY2021Dec 31, 2021-$14.50M–
FY2020Dec 31, 2020-$13.55M–
FY2019Dec 31, 2019-$9.86M–
FY2018Dec 31, 2018-$10.77M–
FY2017Dec 31, 2017-$12.33M–
FY2016Dec 31, 2016-$10.77M–
FY2015Dec 31, 2015-$5.19M–
FY2014Dec 31, 2014-$9.03M–
FY2013Dec 31, 2013-$1.18M–
FY2012Dec 31, 2012-$4.31M–
FY2011Dec 31, 2011-$12.02M–
FY2010Dec 31, 2010-$1.98M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.92M–
Q1 FY2026Mar 31, 2026-$8.02M–
Q4 FY2025Dec 31, 2025-$6.58M–
Q3 FY2025Sep 30, 2025-$6.47M–
Q2 FY2025Jun 30, 2025-$6.51M–
Q1 FY2025Mar 31, 2025-$3.89M–
Q4 FY2024Dec 31, 2024-$8.05M–
Q3 FY2024Sep 30, 2024-$4.85M–
Q2 FY2024Jun 30, 2024-$2.20M–
Q1 FY2024Mar 31, 2024-$1.42M–
Q4 FY2023Dec 31, 2023-$2.54M–
Q3 FY2023Sep 30, 2023-$1.47M-121.4%
Q2 FY2023Jun 30, 2023-$1.96M–
Q1 FY2023Mar 31, 2023-$1.48M–
Q4 FY2022Dec 31, 2022-$692.53K–
Q3 FY2022Sep 30, 2022$6.86M–
Q2 FY2022Jun 30, 2022-$4.01M–
Q1 FY2022Mar 31, 2022-$4.73M–
Q4 FY2021Dec 31, 2021-$3.03M–
Q3 FY2021Sep 30, 2021-$2.97M–
Q2 FY2021Jun 30, 2021-$3.33M–
Q1 FY2021Mar 31, 2021-$5.18M–
Q4 FY2020Dec 31, 2020-$3.39M–
Q3 FY2020Sep 30, 2020-$3.51M–
Q2 FY2020Jun 30, 2020-$3.14M–
Q1 FY2020Mar 31, 2020-$3.50M–
Q4 FY2019Dec 31, 2019-$2.44M–
Q3 FY2019Sep 30, 2019-$2.15M–
Q2 FY2019Jun 30, 2019-$2.61M–
Q1 FY2019Mar 31, 2019-$2.66M–
Q4 FY2018Dec 31, 2018-$3.03M–
Q3 FY2018Sep 30, 2018-$1.92M–
Q2 FY2018Jun 30, 2018-$2.54M–
Q1 FY2018Mar 31, 2018-$3.29M–
Q4 FY2017Dec 31, 2017-$2.28M–
Q3 FY2017Sep 30, 2017-$3.89M–
Q2 FY2017Jun 30, 2017-$2.75M–
Q1 FY2017Mar 31, 2017-$3.42M–
Q4 FY2016Dec 31, 2016-$1.41M–
Q3 FY2016Sep 30, 2016-$1.86M–

More CervoMed figures

See a number that looks wrong?